« Back
Home /
Zoledronic Acid

Zoledronic Acid

Item no.	TMO-T6739-20mg
Manufacturer	TargetMol
CASRN	118072-93-8
Amount	20 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 20 mg 25 mg 500 mg 50 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,98
Smiles	C(P(=O)(O)O)(P(=O)(O)O)(CN1C=CN=C1)O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Zoledronate,ZOL 446,CGP 42446,Zometa,CGP42446A
Similar products	118072-93-8
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Rho\|\|\|Apoptosis\|\|\|Autophagy
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	272.09
Description	Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronic Acid (ZOL 446) is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis.
Pathways	Cell Cycle/Checkpoint\|\|\|Apoptosis\|\|\|Autophagy
Formulate	C5H10N2O7P2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6739-20mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 20 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question